S-nitrosylation of FLICE inhibitory protein determines its interaction with RIP1 and activation of NF-κB

Area of Science:

• Cellular signaling pathways
• Molecular mechanisms of cell death and survival
• Post-translational modifications

Background:

• Death receptor (DR) ligation triggers diverse cellular outcomes, including apoptosis or proliferation.
• FLICE inhibitory protein (FLIP) modulates both apoptosis and NF-κB activation.
• The precise molecular regulation of FLIP in these pathways remains unclear.

Purpose of the Study:

• To elucidate the regulatory mechanism of FLIP in NF-κB activation.
• To investigate the role of S-nitrosylation in FLIP-mediated signaling.
• To understand the implications of FLIP S-nitrosylation in cancer biology.

Main Methods:

• Investigated FLIP regulation via S-nitrosylation, a modification by nitric oxide.
• Utilized point mutations at cysteine residues 254 and 259 of FLIP.
• Assessed the impact of S-nitrosylation on FLIP binding to RIP1 and TRAF2.
• Examined the effect of nitrosylation status on FLIP processing and cleavage.

Main Results:

• S-nitrosylation of FLIP was identified as a key regulator of NF-κB activation.
• Mutations preventing S-nitrosylation abolished FLIP's ability to activate NF-κB.
• FLIP S-nitrosylation influences RIP1 binding and redistribution, but not TRAF2.
• FLIP processing and cleavage are dependent on its S-nitrosylation status.

Conclusions:

• A novel pathway for FLIP regulation of NF-κB via S-nitrosylation was discovered.
• Protein S-nitrosylation is a critical post-translational mechanism controlling DR-mediated cell death and survival.
• FLIP S-nitrosylation may represent a key mechanism underlying chemoresistance and tumor growth in cancers with elevated FLIP and nitric oxide.